Back
Novo Nordisk AS Vs. Lemonade Industry Stock Comparison
Sell
30
NONOF
Novo Nordisk AS
Last Price:
104.81
Seasonality Move:
9.22%
Buy
91
LMND
Lemonade
Last Price:
32.01
Seasonality Move:
29.67%
Sell
30
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
- The current Novo Nordisk AS [NONOF] share price is $105.43. The Score for NONOF is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- NONOF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
91
Lemonade (LMND)
is a Buy
Is Lemonade a Buy, Sell or Hold?
- The current Lemonade [LMND] share price is $32.27. The Score for LMND is 91, which is 82% above its historic median score of 50, and infers lower risk than normal.
- LMND is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $105.43
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing selling pressure, which indicates risk of future bearish movement.
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.65 | Sell |
| Relative Strength Index (14 RSI): | 38.55 | Sell |
| Chaikin Money Flow: | -2187 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (108.86 - 118.26) | Sell |
| Bollinger Bands (100): | (116.88 - 138.88) | Sell |
LMND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.5 | Buy |
| Relative Strength Index (14 RSI): | 74.87 | Buy |
| Chaikin Money Flow: | -2225126 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.38 - 26.6) | Buy |
| Bollinger Bands (100): | (15.39 - 22.43) | Buy |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 108.51 | Sell |
| 20-day SMA: | 112.14 | Sell |
| 50-day SMA: | 120.1 | Sell |
| 200-day SMA: | 128.19 | Sell |
| 8-day EMA: | 108.5 | Sell |
| 20-day EMA: | 111.75 | Sell |
| 50-day EMA: | 118.2 | Sell |
| 200-day EMA: | 121.75 | Sell |
LMND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.04 | Buy |
| 20-day SMA: | 22.66 | Buy |
| 50-day SMA: | 19.53 | Buy |
| 200-day SMA: | 17.84 | Buy |
| 8-day EMA: | 28.45 | Buy |
| 20-day EMA: | 24.22 | Buy |
| 50-day EMA: | 20.89 | Buy |
| 200-day EMA: | 18.31 | Buy |
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
Lemonade Earnings Growth & LMND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and an increase next year of $0.41 per share.
Novo Nordisk AS Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lemonade Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||